CIK 0001590750
- Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471187261
- Phone
- +1 617-272-4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-03 | Smith Robin L Director | Exercise or conversion | +1,200 | $7.65 | $9K | 1,900 |
| 2017-02-03 | Smith Robin L Director | Exercise or conversion · Stock Option (Right to Buy) | −1,200 | 0 | ||
| 2016-06-15 | Smith Robin L Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2015-08-06 | Smith Robin L Director | Exercise or conversion | +4,125 | 5,500 | ||
| 2015-08-06 | Smith Robin L Director | Grant or award | +5,000 | 10,500 | ||
| 2015-08-06 | Smith Robin L Director | Exercise or conversion · Restricted Stock Units | −4,125 | 0 | ||
| 2015-08-06 | Smith Robin L Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2015-07-17 | Smith Robin L Director | Exercise or conversion | +1,375 | 1,375 | ||
| 2015-07-17 | Smith Robin L Director | Exercise or conversion · Restricted Stock Units | −1,375 | 4,125 | ||
| 2014-07-17 | Smith Robin L Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2014-07-17 | Smith Robin L Director | Grant or award · Restricted Stock Units | +5,500 | 5,500 |
Page 1 of 1 · 11 trades